Profile data is unavailable for this security.
About the company
Spago Nanomedical AB (publ), formerly Spago Imaging publ AB, is a Sweden-based biotechnology company. The Company is a nanomedicine company in clinical development phase, developing products for diagnostics and treatment of life-threatening and debilitating diseases. Its products include SpagoPix (SN132D), an MRI contrast agent, which is under Phase I development stage for the treatment of breast cancer, and under Phase II development stage for the treatment liver and pancreas cancer, as well as offers Tumorad (SN201), a radionuclide therapy for treatment of advanced and metastatic cancer, under Preclinical development stage. The Company’s operations are based on a patented material for the design of functional nanoparticles that accumulate physiologically in tumors, thus enabling higher precision in image diagnostics and treatment of cancer and other severe diseases.
- Revenue in SEK (TTM)437.00k
- Net income in SEK-26.55m
- Incorporated1999
- Employees7.00
- LocationSpago Nanomedical AB (publ)Scheelevagen 22LUND 223 63SwedenSWE
- Phone+46 4681188
- Websitehttps://spagonanomedical.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acousort AB | 5.62m | -12.36m | 54.39m | 16.00 | -- | 2.92 | -- | 9.69 | -0.7188 | -0.7188 | 0.3101 | 0.8814 | 0.2799 | -0.0274 | 49.25 | 350,937.50 | -61.61 | -48.79 | -81.29 | -71.44 | 101.21 | 63.17 | -220.12 | -285.72 | 4.51 | -- | 0.00 | -- | -14.40 | 20.61 | 11.77 | -- | -- | -- |
| Chosa Oncology AB | 717.00k | -6.01m | 68.24m | -- | -- | 4.23 | -- | 95.18 | -0.0766 | -0.0766 | 0.0096 | 0.2044 | 0.0382 | -- | 0.8639 | -- | -32.00 | -55.65 | -35.30 | -67.69 | 643.24 | -- | -837.66 | -792.50 | -- | -49.05 | 0.00 | -- | -39.73 | -62.56 | 59.93 | -- | -- | -- |
| Lifecare ASA | 1.70m | -115.45m | 77.21m | 28.00 | -- | -- | -- | 45.36 | -2.48 | -2.48 | 0.0379 | -0.11 | 0.0168 | -- | 0.1582 | 55,272.73 | -115.30 | -52.64 | -194.19 | -61.98 | -- | -- | -6,864.75 | -277.39 | -- | -- | 1.17 | -- | -26.10 | 36.13 | -103.52 | -- | -- | -- |
| IDL Diagnostics AB (publ) | 52.19m | -39.31m | 81.09m | 22.00 | -- | 0.542 | -- | 1.55 | -0.1706 | -0.1706 | 0.2266 | 0.6495 | 0.3263 | 6.59 | 5.26 | 2,372,364.00 | -24.58 | -29.04 | -26.98 | -31.14 | 21.53 | 1.70 | -75.32 | -157.60 | 3.29 | -- | 0.0843 | -- | 33.45 | 164.62 | 28.41 | -- | 18.85 | -- |
| Opsy Holding AB | 4.13m | -18.69m | 86.34m | 7.00 | -- | 55.91 | -- | 20.91 | -20.83 | -20.83 | 0.6321 | 0.1216 | 0.294 | -- | 7.63 | 2,064,500.00 | -133.11 | -117.68 | -201.35 | -142.11 | 154.30 | -- | -452.72 | -- | -- | -216.84 | 0.463 | -- | -- | -- | -43.22 | -- | -- | -- |
| Spago Nanomedical AB (publ) | 437.00k | -26.55m | 87.66m | 7.00 | -- | 2.85 | -- | 200.59 | -0.0513 | -0.0513 | 0.0008 | 0.0465 | 0.0115 | -- | 4.39 | 62,428.57 | -69.64 | -30.44 | -81.41 | -32.48 | -- | -- | -6,076.43 | -3,410.33 | -- | -- | -- | -- | -77.13 | 5.02 | 18.32 | -- | -- | -- |
| Biosergen AB | 0.00 | -30.59m | 99.10m | 2.00 | -- | 4.89 | -- | -- | -13.74 | -13.74 | 0.00 | 8.63 | 0.00 | -- | -- | 0.00 | -152.65 | -- | -191.42 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 29.00 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -20.64m | 101.00m | 3.00 | -- | 8.67 | -- | -- | -0.7859 | -0.7859 | 0.00 | 0.4681 | 0.00 | -- | -- | 0.00 | -85.07 | -133.34 | -91.51 | -179.59 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 15.00 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -38.50m | 102.02m | 5.00 | -- | 13.33 | -- | -- | -0.0737 | -0.0737 | 0.00 | 0.0029 | 0.00 | -- | -- | 0.00 | -241.37 | -94.38 | -927.66 | -120.44 | -- | -- | -- | -3,355.24 | -- | -- | 0.0816 | -- | -- | -- | 13.98 | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -36.89m | 105.18m | 4.00 | -- | 4.22 | -- | -- | -5.98 | -5.98 | 0.00 | 3.53 | 0.00 | -- | -- | 0.00 | -150.00 | -137.53 | -190.93 | -169.50 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 26.58 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -67.39m | 111.01m | 12.00 | -- | 1.76 | -- | -- | -1.40 | -1.40 | 0.00 | 1.07 | 0.00 | -- | -- | 0.00 | -108.82 | -43.50 | -168.39 | -50.76 | -- | -- | -- | -- | -- | -20.18 | 0.0052 | -- | -- | -- | -8.27 | -- | 1.47 | -- |
| Alligator Bioscience AB | 42.25m | -77.72m | 112.25m | 13.00 | -- | -- | -- | 2.66 | -2.16 | -2.16 | 0.6369 | -0.0592 | 0.5013 | -- | 9.35 | 938,822.30 | -92.22 | -97.96 | -- | -155.50 | -- | -- | -183.96 | -569.04 | -- | -- | 1.33 | -- | -0.5851 | 67.68 | 5.91 | -- | -- | -- |
| Glycorex Transplantation AB (publ) | 39.94m | -7.06m | 114.51m | 20.00 | -- | 3.21 | 48.67 | 2.87 | -0.0917 | -0.0917 | 0.5174 | 0.4719 | 0.7442 | 1.45 | 5.20 | 1,997,000.00 | -13.15 | -15.79 | -17.51 | -18.66 | 81.68 | 87.06 | -17.67 | -44.85 | 1.56 | -15.83 | 0.1599 | -- | 17.35 | -0.5296 | 63.97 | -- | -- | -- |
| Abera Bioscience AB | 0.00 | -1.45m | 116.44m | 5.00 | -- | 4.15 | -- | -- | -0.0872 | -0.0872 | 0.00 | 1.51 | 0.00 | -- | -- | 0.00 | -6.61 | -68.96 | -7.94 | -85.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 93.42 | -- | -- | -- |
| Biovica International AB | 9.86m | -76.47m | 120.85m | 24.00 | -- | 1.04 | -- | 12.25 | -0.6375 | -0.6375 | 0.0684 | 0.4241 | 0.0799 | 12.71 | 4.46 | 365,333.30 | -61.92 | -58.22 | -70.41 | -66.49 | -171.53 | -462.09 | -775.22 | -1,804.16 | 8.11 | -- | 0.0239 | -- | 18.23 | 38.83 | 29.80 | -- | -47.26 | -- |
| Alzinova AB | 205.00k | -26.88m | 121.18m | 5.00 | -- | 0.5924 | -- | 591.13 | -0.2846 | -0.2846 | 0.0022 | 1.23 | 0.0015 | -- | 0.3254 | 41,000.00 | -19.42 | -12.21 | -20.69 | -12.85 | -5,834.15 | -- | -13,114.15 | -21,390.81 | -- | -1,794.80 | 0.0062 | -- | -88.89 | -- | -24.71 | -- | 19.48 | -- |
Data as of Feb 11 2026. Currency figures normalised to Spago Nanomedical AB (publ)'s reporting currency: Swedish Krona SEK
